1366664-52-9 Usage
Uses
Used in Pharmaceutical Industry:
(R)-3-Phenoxy-pyrrolidine.HCl is used as an anti-inflammatory agent for its potential to reduce inflammation and alleviate associated symptoms. Its structure allows it to interact with biological targets, making it a candidate for the development of new anti-inflammatory drugs.
(R)-3-Phenoxy-pyrrolidine.HCl is also used as an antineoplastic agent, indicating its potential role in treating cancer by inhibiting tumor growth and proliferation. Its unique chemical properties may allow it to target cancer cells specifically, minimizing damage to healthy cells.
Furthermore, (R)-3-Phenoxy-pyrrolidine.HCl is used as an antithrombotic agent, which implies its potential application in preventing blood clot formation. This could be particularly beneficial in managing conditions associated with increased risk of thrombosis.
Used in Agrochemical Industry:
In the agrochemical sector, (R)-3-Phenoxy-pyrrolidine.HCl may be utilized for its potential applications in pest control or as a component in the development of new herbicides or pesticides. Its unique chemical structure could provide novel modes of action against various agricultural pests and weeds, enhancing crop protection strategies.
As research progresses, the specific applications and benefits of (R)-3-Phenoxy-pyrrolidine.HCl in these industries may become more clearly defined, potentially leading to the development of new products and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 1366664-52-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,6,6,6 and 4 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1366664-52:
(9*1)+(8*3)+(7*6)+(6*6)+(5*6)+(4*6)+(3*4)+(2*5)+(1*2)=189
189 % 10 = 9
So 1366664-52-9 is a valid CAS Registry Number.
1366664-52-9Relevant academic research and scientific papers
SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
-
Page/Page column 232; 233, (2017/12/13)
This application discloses compounds according to generic Formula (I): wherein all variables are defined as described herein which exhibit strong inhibition effects on various cancer cell lines. The compounds disclosed herein are useful for the treatment of proliferative diseases, including neoplastic diseases such as cancer and non- neoplastic disorders such as rheumatoid arthritis. Also disclosed are pharmaceutical compositions containing compounds of Formula (I) and at least one carrier, diluent or excipient and optionally one or more additional therapeutically active agents, including anticancer agents. This application also discloses methods for treating a proliferative disease, including neoplastic diseases such as cancer and non- neoplastic disorders such as rheumatoid arthritis.
NOVEL HETEROCYCLIC ACRYLAMIDES AND THEIR USE AS PHARMACEUTICALS
-
Page/Page column 48, (2011/06/19)
The invention relates to novel heterocyclic acrylamide compounds (I), to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.
CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
-
Page/Page column 43, (2008/06/13)
The invention relates to compounds of Formula (I) processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
